NMLSF.US Nova Mentis Life Science Corp

Healthcare Biotechnology USA Stocks
0.0633 USD
Close of Nov 15, 2026
0.0101 0.1242
Market cap
USD 3.96M
P/E
-
P/B
4.26x
ROE
-202.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is NMLSF.US undervalued?

Graham number

The Graham number of Nova Mentis Life Science Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nova Mentis Life Science Corp fundamental analysis

No fundamental analysis for Nova Mentis Life Science Corp yet.

Nova Mentis Life Science Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nova Mentis Life Science Corp

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company in Canada. It engages in research and development of psilocybin; and fund food-related research initiative in support of its expanding portfolio of consumer health and wellness products. The company has collaboration with the University of Manitoba's Richardson Centre for food technology and research (RCFTR) to support a series of food-related scientific studies, including the developm…

Full company profile